Treatment for Healthy Controls

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Cleveland Clinic, Cleveland, OH
Healthy Controls
Eligibility
18+
All Sexes
Eligible conditions
Select

Study Summary

HA35 Acute Alcohol Study

See full description

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Healthy Controls

Study Objectives

This trial is evaluating whether Treatment will improve 2 primary outcomes in patients with Healthy Controls. Measurement will happen over the course of Baseline to day 4.

Baseline to day 4
Change in Alanine Aminotransferase (ALT)
Change in Aspartate Aminotransferase (AST)

Trial Safety

Safety Progress

1 of 3

Other trials for Healthy Controls

Trial Design

2 Treatment Groups

HA35 Treatment Group
1 of 2
HA35 Placebo Group
1 of 2
Active Control
Non-Treatment Group

This trial requires 24 total participants across 2 different treatment groups

This trial involves 2 different treatments. Treatment is the primary treatment being studied. Participants will all receive the same treatment. Some patients will receive a placebo treatment. The treatments being tested are in Phase < 1 and are in the first stage of evaluation with people.

HA35 Treatment Group
Drug
12 study participants will be given an HA35 capsule to take once per day in the morning with breakfast for 3 days.
HA35 Placebo Group
Drug
12 study participants will be given a placebo capsule to take once per day in the morning with breakfast for 3 days.

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline to day 4
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly baseline to day 4 for reporting.

Who is running the study

Principal Investigator
S. D.
Srinivasan Dasarathy, Staff Physician
The Cleveland Clinic

Closest Location

Cleveland Clinic - Cleveland, OH

Eligibility Criteria

This trial is for patients born any sex aged 18 and older. There are 2 eligibility criteria to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
Alcohol consumption of less than 7 drinks per week for women and less than 14 drinks per week for men
Ability to understand and willingness to provide written consent

Patient Q&A Section

Ask a question about the study

Other questions from users

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any geographic restrictions to consider when applying for this trial?

Patients from any state can participate in this trial, so long as they are able to attend all treatment sessions.

Will my insurance cover participating in this trial?

There is not cost involved in participating in this trial, so insurance won't be necessary.

See if you qualify for this trial
Get access to this novel treatment for Healthy Controls by sharing your contact details with the study coordinator.